Sex-by-treatment interaction [Design Issues]

posted by Helmut Homepage – Vienna, Austria, 2023-05-05 14:44 (296 d 02:41 ago) – Posting: # 23544
Views: 1,102

Hi BEQool,

❝ […] is Gender*Treatment also a between-subject factor (like Sequence and Gender here)?


If you replace gender by sex, yes. Muse about it. ;-) BTW, you could even drop sequence from the model

❝ In the article Evaluation of sex-by-formulation interaction in bioequivalence studies of efavirenz tablets by González-Rojano et al. it doesnt say anything about which factor they used (within- or between-subject) to test Gender*Treatment interaction.


See p. 1731, right column, top. That’s the model proposed by the FDA earlier:*$$\eqalign{Y&|\;\text{sequence},\,\text{sex},\,\text{sequence}\,\times\,\text{sex},\\
&\phantom{|}\;\text{subject}(\text{sequence}\,\times\text{sex}),\;\text{period},\\
&\phantom{|}\;\text{treatment},\,\text{sex}\,\times\,\text{treatment}}$$ I employed it also in my meta-analysis. The ‘purpose’ of this model is only to assess the interaction. Since treatment appears twice in the model, it is not possible to get an unbiased estimate of it (for a similar story see this article).

❝ Additionally, how do you know which factor is a within-subject and which is a between-subject? If anyone has an explanation in simple words :-)


In simple words? I’ll try. For a given subject anything which remains constant throughout a study leads to a between-subject factor (e.g., sex, sequence, stage, group, site). Everything else leads to a within-subject factor (e.g., treatment, period).



Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,911 posts in 4,806 threads, 1,635 registered users;
28 visitors (0 registered, 28 guests [including 6 identified bots]).
Forum time: 16:25 CET (Europe/Vienna)

The history of statistics is like a telephone directory:
the plot is boring, full of numbers and the cast is endless.    Stephen Senn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5